Skip to main content
Premium Trial:

Request an Annual Quote

Patent Categories

A new study published in the European Journal of Human Genetics says that some gene patents are "problematic" as they have the potential to hinder patient access to diagnostics. Coming on the heels of the recent news from the US on Myriad Genetics' BRCA gene patents, the study examines concerns about how gene patents affect diagnosticians and patients, and develops a "patent categorization method" to determine which patents could cause a problem. The authors apply this method to patents relevant for genetic testing of spinocerebellar ataxia, the most widely used DNA test in adult neurology. The test is typically done as a gene panel covering the five most common SCA subtypes. "We show that the patenting of SCA genes and testing methods and the associated licensing conditions could have far-reaching consequences on legitimate access to this gene panel," the authors write. "Moreover, with genetic testing being increasingly standardized, simply ignoring patents is unlikely to hold out indefinitely." The current patenting landscape cannot continue as is, the authors conclude, adding that there is a need for more licensing and collaboration in diagnostics.

The Scan

Tennessee's COVID-19 Sequencing

The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.

Charged with Sanction Violations

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.